Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1314075 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA | CTD | PMID:22079256 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of TFDP2 mRNA | CTD | PMID:28960355 | 17alpha-ethynylestradiol | decreases expression | ISO | RGD:1314075 | 6480464 | Ethinyl Estradiol results in decreased expression of TFDP2 mRNA | CTD | PMID:18936297 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of TFDP2 mRNA | CTD | PMID:21570461, PMID:24058054 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1314075 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TFDP2 mRNA | CTD | PMID:12377990 | 2-butoxyethanol | increases expression | EXP | | 6480464 | n-butoxyethanol results in increased expression of TFDP2 mRNA | CTD | PMID:19812364 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | EXP | | 6480464 | tetrabromobisphenol A results in decreased expression of TFDP2 mRNA | CTD | PMID:25172293 | 4-hydroxynon-2-enal | decreases expression | ISO | RGD:1314075 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of TFDP2 mRNA | CTD | PMID:12419474 | acetamide | decreases expression | ISO | RGD:1305814 | 6480464 | acetamide results in decreased expression of TFDP2 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | RGD:1314075 | 6480464 | Aflatoxin B1 results in decreased methylation of TFDP2 intron | CTD | PMID:30157460 | aflatoxin B2 | decreases methylation | ISO | RGD:1314075 | 6480464 | aflatoxin B2 results in decreased methylation of TFDP2 intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | RGD:1314075 | 6480464 | Tretinoin results in decreased expression of TFDP2 mRNA | CTD | PMID:15498508, PMID:16129123 | arsane | increases expression | ISO | RGD:1314075 | 6480464 | Arsenic results in increased expression of TFDP2 mRNA | CTD | PMID:11134558 | arsenic atom | increases expression | ISO | RGD:1314075 | 6480464 | Arsenic results in increased expression of TFDP2 mRNA | CTD | PMID:11134558 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzoapyrene results in decreased expression of TFDP2 mRNA | CTD | PMID:21715664 | benzo[a]pyrene | affects methylation | ISO | RGD:1314075 | 6480464 | Benzoapyrene affects the methylation of TFDP2 intron | CTD | PMID:30157460 | benzo[a]pyrene | decreases expression | ISO | RGD:1314075 | 6480464 | Benzoapyrene results in decreased expression of TFDP2 mRNA | CTD | PMID:20106945, PMID:21632981 | benzo[e]pyrene | decreases methylation | ISO | RGD:1314075 | 6480464 | benzoepyrene results in decreased methylation of TFDP2 intron | CTD | PMID:30157460 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TFDP2 mRNA | CTD | PMID:26063408 | bisphenol A | decreases expression | ISO | RGD:1305814 | 6480464 | bisphenol A results in decreased expression of TFDP2 mRNA | CTD | PMID:30816183 | bisphenol A | affects methylation | EXP | | 6480464 | bisphenol A affects the methylation of TFDP2 promoter | CTD | PMID:27334623 | bisphenol A | affects expression | ISO | RGD:1305814 | 6480464 | bisphenol A affects the expression of TFDP2 mRNA | CTD | PMID:25181051 | cadmium dichloride | increases expression | ISO | RGD:1314075 | 6480464 | Cadmium Chloride results in increased expression of TFDP2 mRNA | CTD | PMID:12160620, PMID:26472689 | cadmium dichloride | decreases expression | ISO | RGD:1305814 | 6480464 | Cadmium Chloride results in decreased expression of TFDP2 mRNA | CTD | PMID:31077537 | cadmium dichloride | multiple interactions | ISO | RGD:1305814 | 6480464 | [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TFDP2 mRNA | CTD | PMID:31077537 | calcitriol | decreases expression | ISO | RGD:1314075 | 6480464 | Calcitriol results in decreased expression of TFDP2 mRNA | CTD | PMID:16129123 | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes, Carbon analog results in increased expression of TFDP2 mRNA | CTD | PMID:25620056 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA | CTD | PMID:20938992 | cisplatin | decreases expression | ISO | RGD:1305814 | 6480464 | Cisplatin results in decreased expression of TFDP2 mRNA | CTD | PMID:22023808 | cisplatin | decreases expression | ISO | RGD:1314075 | 6480464 | Cisplatin results in decreased expression of TFDP2 mRNA | CTD | PMID:27594783 | cobalt dichloride | increases expression | ISO | RGD:1314075 | 6480464 | cobaltous chloride results in increased expression of TFDP2 mRNA | CTD | PMID:19320972 | cobalt dichloride | decreases expression | ISO | RGD:1314075 | 6480464 | cobaltous chloride results in decreased expression of TFDP2 mRNA | CTD | PMID:22941251 | cocaine | increases expression | ISO | RGD:1305814 | 6480464 | Cocaine results in increased expression of TFDP2 mRNA | CTD | PMID:17898221 | copper(II) chloride | affects expression | ISO | RGD:1314075 | 6480464 | cupric chloride affects the expression of TFDP2 mRNA | CTD | PMID:17211630 | crocidolite asbestos | decreases expression | EXP | | 6480464 | Asbestos, Crocidolite results in decreased expression of TFDP2 mRNA | CTD | PMID:29279043 | diallyl disulfide | multiple interactions | ISO | RGD:1305814 | 6480464 | [Cadmium Chloride co-treated with diallyl disulfide] results in decreased expression of TFDP2 mRNA | CTD | PMID:31077537 | diazinon | affects expression | ISO | RGD:1305814 | 6480464 | Diazinon affects the expression of TFDP2 mRNA | CTD | PMID:22546817 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of TFDP2 mRNA | CTD | PMID:17361019, PMID:21266533 | dieldrin | affects expression | ISO | RGD:1305814 | 6480464 | Dieldrin affects the expression of TFDP2 mRNA | CTD | PMID:22546817 | diethylstilbestrol | decreases expression | ISO | RGD:1305814 | 6480464 | Diethylstilbestrol results in decreased expression of TFDP2 mRNA | CTD | PMID:21658437 | dioxygen | multiple interactions | EXP | | 6480464 | Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of TFDP2 mRNA] | CTD | PMID:22629407 | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of TFDP2 mRNA | CTD | PMID:22629407 | dorsomorphin | multiple interactions | ISO | RGD:1314075 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of TFDP2 mRNA | CTD | PMID:25896364 | endosulfan | decreases expression | ISO | RGD:1305814 | 6480464 | Endosulfan results in decreased expression of TFDP2 mRNA | CTD | PMID:29391264 | entinostat | decreases expression | ISO | RGD:1314075 | 6480464 | entinostat results in decreased expression of TFDP2 mRNA | CTD | PMID:26272509, PMID:27188386 | entinostat | multiple interactions | ISO | RGD:1314075 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TFDP2 mRNA | CTD | PMID:27188386 | ethyl methanesulfonate | increases expression | ISO | RGD:1314075 | 6480464 | Ethyl Methanesulfonate results in increased expression of TFDP2 mRNA | CTD | PMID:23649840 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA | CTD | PMID:20938992 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of TFDP2 mRNA | CTD | PMID:25629700 | formaldehyde | increases expression | ISO | RGD:1314075 | 6480464 | Formaldehyde results in increased expression of TFDP2 mRNA | CTD | PMID:23649840 | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of TFDP2 mRNA | CTD | PMID:20003209 | isotretinoin | decreases expression | ISO | RGD:1314075 | 6480464 | Isotretinoin results in decreased expression of TFDP2 mRNA | CTD | PMID:20436886 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of TFDP2 mRNA | CTD | PMID:20938992 | lead(0) | affects expression | ISO | RGD:1314075 | 6480464 | Lead affects the expression of TFDP2 mRNA | CTD | PMID:28903495 | lead(2+) | affects expression | ISO | RGD:1314075 | 6480464 | Lead affects the expression of TFDP2 mRNA | CTD | PMID:28903495 | methapyrilene | decreases methylation | ISO | RGD:1314075 | 6480464 | Methapyrilene results in decreased methylation of TFDP2 intron | CTD | PMID:30157460 | methylmercury chloride | decreases expression | ISO | RGD:1314075 | 6480464 | methylmercuric chloride results in decreased expression of TFDP2 mRNA | CTD | PMID:28001369 | N(6)-dimethylallyladenine | decreases expression | ISO | RGD:1314075 | 6480464 | N6-delta2-isopentenyladenine results in decreased expression of TFDP2 mRNA | CTD | PMID:16129123 | nickel atom | decreases expression | ISO | RGD:1314075 | 6480464 | Nickel results in decreased expression of TFDP2 mRNA | CTD | PMID:24768652, PMID:25583101 | ochratoxin A | multiple interactions | ISO | RGD:1314075 | 6480464 | [ochratoxin A results in decreased acetylation of TFDP2 promoter] which results in decreased expression of TFDP2 mRNA | CTD | PMID:29098329 | ochratoxin A | decreases acetylation | ISO | RGD:1314075 | 6480464 | ochratoxin A results in decreased acetylation of TFDP2 promoter | CTD | PMID:29098329 | ochratoxin A | decreases expression | ISO | RGD:1314075 | 6480464 | ochratoxin A results in decreased expression of TFDP2 mRNA | CTD | PMID:29098329 | oxaliplatin | multiple interactions | ISO | RGD:1305814 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TFDP2 mRNA | CTD | PMID:25729387 | p-chloromercuribenzoic acid | decreases expression | ISO | RGD:1314075 | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of TFDP2 mRNA | CTD | PMID:26272509 | p-chloromercuribenzoic acid | multiple interactions | ISO | RGD:1314075 | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TFDP2 mRNA | CTD | PMID:27188386 | p-menthan-3-ol | decreases expression | ISO | RGD:1314075 | 6480464 | Menthol results in decreased expression of TFDP2 mRNA | CTD | PMID:26760959 | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TFDP2 mRNA] | CTD | PMID:19482888 | phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of TFDP2 mRNA | CTD | PMID:19482888 | phenylmercury acetate | decreases expression | ISO | RGD:1314075 | 6480464 | Phenylmercuric Acetate results in decreased expression of TFDP2 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | RGD:1314075 | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TFDP2 mRNA | CTD | PMID:27188386 | potassium chromate | multiple interactions | ISO | RGD:1314075 | 6480464 | [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of TFDP2 mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | RGD:1314075 | 6480464 | potassium chromateVI results in decreased expression of TFDP2 mRNA | CTD | PMID:22079256 | potassium dichromate | affects expression | EXP | | 6480464 | Potassium Dichromate affects the expression of TFDP2 mRNA | CTD | PMID:23608068 | quercetin | decreases expression | ISO | RGD:1314075 | 6480464 | Quercetin results in decreased expression of TFDP2 mRNA | CTD | PMID:21632981 | SB 431542 | multiple interactions | ISO | RGD:1314075 | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... | CTD | PMID:27188386 | silver(1+) nitrate | increases expression | ISO | RGD:1314075 | 6480464 | Silver Nitrate analog results in increased expression of TFDP2 mRNA | CTD | PMID:22831968 | Soman | increases expression | ISO | RGD:1305814 | 6480464 | Soman results in increased expression of TFDP2 mRNA | CTD | PMID:19281266 | succimer | multiple interactions | EXP | | 6480464 | [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA | CTD | PMID:21641980 | tamibarotene | decreases expression | ISO | RGD:1314075 | 6480464 | tamibarotene results in decreased expression of TFDP2 mRNA | CTD | PMID:15498508 | tamoxifen | increases expression | ISO | RGD:1314075 | 6480464 | Tamoxifen results in increased expression of TFDP2 mRNA | CTD | PMID:15590111 | testosterone undecanoate | decreases expression | ISO | RGD:1314075 | 6480464 | testosterone undecanoate results in decreased expression of TFDP2 mRNA | CTD | PMID:19074003 | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of TFDP2 mRNA | CTD | PMID:17484886 | tetrachloromethane | decreases expression | ISO | RGD:1305814 | 6480464 | Carbon Tetrachloride results in decreased expression of TFDP2 mRNA | CTD | PMID:31150632 | topotecan | multiple interactions | ISO | RGD:1305814 | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of TFDP2 mRNA | CTD | PMID:25729387 | topotecan | decreases expression | ISO | RGD:1305814 | 6480464 | Topotecan results in decreased expression of TFDP2 mRNA | CTD | PMID:25729387 | tremolite asbestos | decreases expression | EXP | | 6480464 | tremolite results in decreased expression of TFDP2 mRNA | CTD | PMID:29279043 | trichloroethene | increases methylation | ISO | RGD:1305814 | 6480464 | Trichloroethylene results in increased methylation of TFDP2 gene | CTD | PMID:27618143 | trichostatin A | decreases expression | ISO | RGD:1314075 | 6480464 | trichostatin A results in decreased expression of TFDP2 mRNA | CTD | PMID:26272509 | trichostatin A | multiple interactions | ISO | RGD:1314075 | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in decreased expression of TFDP2 mRNA | CTD | PMID:27188386 | Triptolide | increases expression | ISO | RGD:1305814 | 6480464 | triptolide results in increased expression of TFDP2 mRNA | CTD | PMID:23639586 | urethane | increases expression | ISO | RGD:1314075 | 6480464 | Urethane results in increased expression of TFDP2 mRNA | CTD | PMID:28818685 | valproic acid | decreases expression | ISO | RGD:1314075 | 6480464 | Valproic Acid results in decreased expression of TFDP2 mRNA | CTD | PMID:23179753, PMID:28001369 | valproic acid | affects expression | ISO | RGD:1314075 | 6480464 | Valproic Acid affects the expression of TFDP2 mRNA | CTD | PMID:25979313 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| Save what matters to you |
| {{ loginError }} |
| Sign in with your RGD account |
| Create New Account | Recover Password |
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Molecular Pathway Annotations Click to see Annotation Detail View
Imported Annotations - KEGG (archival)
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
Gene Ontology Annotations
Click to see Annotation Detail View
Biological Process
|
|
|
Cellular Component
|
|
Molecular Function
|
|
|
References
References - curated
| 1. | MGD data from the GO Consortium |
| 2. | Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73. |
| 3. | Pipeline to import KEGG annotations from KEGG into RGD |
| 4. | RGD automated import pipeline for gene-chemical interactions |
Additional References at PubMed
| PMID:7478568 | PMID:8923205 | PMID:9000141 | PMID:9878064 | PMID:10349636 | PMID:10512203 | PMID:11042159 | PMID:11076861 | PMID:11217851 | PMID:11591818 | PMID:12477932 | PMID:12520002 |
| PMID:12588846 | PMID:12904583 | PMID:14610273 | PMID:15282318 | PMID:15618518 | PMID:15840001 | PMID:16141072 | PMID:16141073 | PMID:16325481 | PMID:16482218 | PMID:16783635 | PMID:17967808 |
| PMID:18799693 | PMID:20059953 | PMID:20211142 | PMID:20412781 | PMID:21194568 | PMID:21267068 | PMID:21440680 | PMID:21677750 | PMID:21873635 | PMID:22898775 | PMID:24607859 | PMID:24952961 |
Genomics
